Tscan Therapeutics Stock Price on March 1, 2023
| TCRX Stock | USD 3.33 1.31 28.23% |
If you're considering investing in Tscan Stock, it is important to understand the factors that can impact its price. As of today, the current price of Tscan Therapeutics stands at 3.33, as last reported on the 11th of December 2024, with the highest price reaching 3.33 and the lowest price hitting 3.33 during the day. Tscan Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Tscan Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tscan Therapeutics' Variance of 26.23, coefficient of variation of (718.75), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide.
At this time, Tscan Therapeutics' Issuance Of Capital Stock is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.36 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 77.3 M in 2024. . At this time, Tscan Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.09 in 2024, whereas Price To Sales Ratio is likely to drop 17.26 in 2024. Tscan Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Tscan |
Sharpe Ratio = -0.1248
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TCRX |
Estimated Market Risk
| 5.18 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.65 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tscan Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tscan Therapeutics by adding Tscan Therapeutics to a well-diversified portfolio.
Price Book 1.046 | Enterprise Value Ebitda 0.3916 | Price Sales 26.4516 | Shares Float 31.1 M | Wall Street Target Price 12.5714 |
Tscan Therapeutics Valuation on March 1, 2023
It is possible to determine the worth of Tscan Therapeutics on a given historical date. On March 1, 2023 Tscan was worth 2.85 at the beginning of the trading date compared to the closed value of 3.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tscan Therapeutics stock. Still, in general, we apply an absolute valuation method to find Tscan Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tscan Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tscan Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.92 | 3.00 | 2.85 | 2.95 | 54,100 | |
03/01/2023 | 2.85 | 3.25 | 2.85 | 3.15 | 92,254 |
| 3.05 | 3.39 | 3.02 | 3.17 | 65,461 |
| Backtest Tscan Therapeutics | | | Tscan Therapeutics History | | | Tscan Therapeutics Valuation | Previous | Next |
Tscan Therapeutics Trading Date Momentum on March 1, 2023
| On March 02 2023 Tscan Therapeutics was traded for 3.17 at the closing time. The top price for the day was 3.39 and the lowest listed price was 3.02 . The trading volume for the day was 65.5 K. The trading history from March 2, 2023 was a factor to the next trading day price jump. The trading price change against the next closing price was 0.63% . The trading price change against the current closing price is 9.52% . |
Tscan Therapeutics Fundamentals Correlations and Trends
By evaluating Tscan Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tscan Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tscan financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tscan Therapeutics Stock history
Tscan Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tscan is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tscan Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tscan Therapeutics stock prices may prove useful in developing a viable investing in Tscan Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65.6 M | 36 M | |
| Net Loss | -59.6 M | -62.6 M |
Tscan Therapeutics Quarterly Net Working Capital |
|
Tscan Therapeutics Stock Technical Analysis
Tscan Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tscan Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Tscan Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tscan Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Tscan Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tscan Therapeutics shares will generate the highest return on investment. By undertsting and applying Tscan Therapeutics stock market strength indicators, traders can identify Tscan Therapeutics entry and exit signals to maximize returns
Tscan Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tscan Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tscan Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tscan to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.03) | |||
| Total Risk Alpha | (1.53) | |||
| Treynor Ratio | (0.27) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Tscan Stock Analysis
When running Tscan Therapeutics' price analysis, check to measure Tscan Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tscan Therapeutics is operating at the current time. Most of Tscan Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tscan Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tscan Therapeutics' price. Additionally, you may evaluate how the addition of Tscan Therapeutics to your portfolios can decrease your overall portfolio volatility.